Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review

Date: August 1, 2017
Pages: 43
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: E024E5DBD81EN
Leaflet:

Download PDF Leaflet

Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review
Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Elite Pharmaceuticals Inc (Elite) is a specialty pharmaceutical company focuses on the development of oral sustained and controlled release products. The company’s product portfolio includes phentermine tablets, Lodrane D, methadone tablets and hydromorphone hydrochloride tablets and dantrolene sodium, among others, which are commercialized products either owned, licensed or contract manufactured. It develops its products in the areas of pain management, bariatric, cardiovascular, infection and allergy. Elite also has pipeline of abuse-deterrent opioids for the treatment of chronic pain. The company uses its proprietary abuse-deterrent technology, ART, for the development and manufacturing of oral, controlled-release products. Elite is headquartered in Northvale, New Jersey, the US.

Elite Pharmaceuticals Inc Key Recent Developments

Jun 14,2017: Elite Pharmaceuticals, Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information
May 31,2017: Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 30,2017: Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
Apr 04,2017: Elite Pharmaceuticals Files ANDA for Pain Product
Feb 09,2017: Elite Pharmaceuticals Reports Results For Third Quarter Of Fiscal Year 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Elite Pharmaceuticals Inc - Key Facts
Elite Pharmaceuticals Inc - Key Employees
Elite Pharmaceuticals Inc - Key Employee Biographies
Elite Pharmaceuticals Inc - Major Products and Services
Elite Pharmaceuticals Inc - History
Elite Pharmaceuticals Inc - Company Statement
Elite Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Elite Pharmaceuticals Inc - Business Description
Elite Pharmaceuticals Inc - Corporate Strategy
Elite Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Elite Pharmaceuticals Inc - Strengths
Elite Pharmaceuticals Inc - Weaknesses
Elite Pharmaceuticals Inc - Opportunities
Elite Pharmaceuticals Inc - Threats
Elite Pharmaceuticals Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Elite Pharmaceuticals Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Jun 14, 2017: Elite Pharmaceuticals, Reports Financial Results for the Fiscal Year Ended March 31, 2017 and Provides Conference Call Information
May 31, 2017: Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology
May 30, 2017: Elite Pharmaceuticals Reports Positive Topline Results from a Pivotal Bioequivalence Study
Feb 09, 2017: Elite Pharmaceuticals Reports Results For Third Quarter Of Fiscal Year 2017
Nov 09, 2016: Elite Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2017
Aug 09, 2016: Elite Pharmaceuticals Reports Financial Results for the First Quarter of Fiscal Year 2017
May 04, 2016: Elite Pharmaceuticals Appoints Davis S. Caskey to Its Board of Directors
Apr 12, 2016: Elite Pharmaceuticals Announces Changes to their Board of Directors
Jan 13, 2016: Nasrat Hakim Named Chairman Of Board Of Directors For Elite Pharmaceuticals

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Elite Pharmaceuticals Inc, Key Facts
Elite Pharmaceuticals Inc, Key Employees
Elite Pharmaceuticals Inc, Key Employee Biographies
Elite Pharmaceuticals Inc, Major Products and Services
Elite Pharmaceuticals Inc, History
Elite Pharmaceuticals Inc, Subsidiaries
Elite Pharmaceuticals Inc, Key Competitors
Elite Pharmaceuticals Inc, Ratios based on current share price
Elite Pharmaceuticals Inc, Annual Ratios
Elite Pharmaceuticals Inc, Annual Ratios (Cont.1)
Elite Pharmaceuticals Inc, Annual Ratios (Cont.2)
Elite Pharmaceuticals Inc, Interim Ratios
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Elite Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Elite Pharmaceuticals Inc, Performance Chart (2013 - 2017)
Elite Pharmaceuticals Inc, Ratio Charts
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Elite Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

Sandoz Inc
Purdue Pharma LP
Par Pharmaceutical Holdings Inc
Pain Therapeutics Inc
Mylan Laboratories Ltd
Impax Laboratories Inc
DURECT Corp
Collegium Pharmaceutical Inc
Avadel Pharmaceuticals Plc
Allergan Plc
Acura Pharmaceuticals Inc
Skip to top


Ask Your Question

Elite Pharmaceuticals Inc (ELTP) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: